The above results show that the absence of FADD can lead to a decrease in dasatinib‐induced apoptosis in cancer cells, suggesting that the activated extrinsic apoptotic pathway is key to dasatinib‐induced apoptosis. This evidence concerns the gene FADD and cancer.